TITLE

Psychological and Behavioral Correlates of Entering Care for HIV Infection: The Antiretroviral Treatment Access Study (ARTAS)

AUTHOR(S)
Gardner, Lytt I.; Marks, Gary; Metsch, Lisa R.; Loughlin, Anita M.; O'Daniels, Christine; Del Rio, Carlos; Anderson-Mahoney, Pamela; Wilkinson, James D.
PUB. DATE
June 2007
SOURCE
AIDS Patient Care & STDs;Jun2007, Vol. 21 Issue 6, p418
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The present study sought to examine psychological and behavioral variables as predictors of attending an HIV medical care provider among person's recently diagnosed with HIV. The study, carried out between 2001 and 2003, was a two-arm randomized intervention trial with participants recruited from public HIV testing centers, sexually transmitted disease (STD) clinics, hospitals, and community-based organizations in Atlanta, Georgia; Baltimore, Maryland; Miami, Florida; and Los Angeles, California. Eighty-six percent of those enrolled (273) had complete baseline and 12-month follow-up data. Measures of number of months since HIV diagnosis, readiness to enter care (based on stages of change), barriers and facilitators to entering care, drug use, and intervention arm (case managed versus simple referral) were examined as predictors of attending an HIV care provider, defined as being in care at least once in each of two consecutive 6–month follow-up periods. In logistic regression, seeing a care provider was significantly more likely among participants diagnosed with HIV within 6 months of enrollment (odds ratio [OR] = 2.52, 95% confidence interval [CI], 1.25, 5.06), those in the preparation versus precontemplation stages at baseline (OR = 2.87, 95% CI, 1.21, 6.81), those who reported at baseline that someone (friend, family member, social worker, other) was helping them get into care (OR = 2.13, 95% CI, 1.02, 4.44), and those who received a case manager intervention (OR = 2.16, 95% CI, 1.23, 3.78). The findings indicate a need to reach HIV-positive person's soon after diagnosis and assist them in getting into medical care. Knowing a person's stages of readiness to enter care and their support networks can help case managers formulate optimal client plans.
ACCESSION #
25536581

 

Related Articles

  • Use of rapid HIV testing in a low threshold centre in Antwerp, Belgium, 2007–2012. Wouters, Kristien; Fransen, Katrien; Beelaert, Greet; Kenyon, Chris; Platteau, Tom; Van Ghyseghem, Chris; Collier, Ilse; Buyze, Jozefien; Florence, Eric // International Journal of STD & AIDS;Nov2014, Vol. 25 Issue 13, p936 

    The Antwerp Helpcenter is a low threshold screening centre for HIV and STI testing focused on high-risk groups. The aim of this work is to describe our experience with the use of rapid HIV tests including the analysis of the characteristics of new cases of HIV infection. We performed a...

  • An update on diagnosing STIs and HIV. Spiragelli, Michael G.; Biro, Frank M. // Contemporary OB/GYN;May2005, Vol. 50 Issue 5, p76 

    Describes both the traditional and latest methods for diagnosing sexually transmitted diseases and HIV infection in the U.S. Diagnostic methodologies for bacterial vaginosis; Methods used for the diagnosis of Chlamydia trachomatis; Diagnosis of Neisseria gonorrhoeae and Trichomonas vaginalis;...

  • Self triage for sexual health concerns. Bhardwa, Seeta // Independent Nurse;7/20/2015, p6 

    No abstract available.

  • Exploring the sexual histories of older GUM clinic attenders. Gott, C. Merryn; Rogstad, Karen E.; Riley, Vincent; Ahmed-Jushuf, Imtyaz; Green, Tana; Gott, C M; Rogstad, K E; Riley, V; Ahmed-Jushuf, I; Green, T // International Journal of STD & AIDS;Nov2000, Vol. 11 Issue 11, p714 

    Little is known either of the factors motivating clinic attendance in later life, or the sexual health histories of older clinic attenders. A self-administered questionnaire study linked to patient note data aiming to explore these issues was undertaken within 3 genitourinary medicine (GUM)...

  • Testing and Treatment After Non-Occupational Exposures To STDs and HIV. Hardy, Erica J. // Medicine & Health Rhode Island;Aug2012, Vol. 95 Issue 8, p258 

    The article discusses the new recommendations for the prophylaxis, testing, and treatment of adult patients after non-occupational exposures to sexually transmitted disease (STD) and human immunodeficiency virus (HIV). It states that enough time may not have elapsed for a STD test to be positive...

  • Recency and frequency of HIV testing among men who have sex with men in Germany and socio-demographic factors associated with testing behaviour. Marcus, Ulrich; Gassowski, Martyna; Kruspe, Martin; Drewes, Jochen // BMC Public Health;Jul2015, Vol. 15 Issue 1, p1 

    Background: Testing for presence of HIV infection is a pre-requisite to qualify for antiretroviral treatment. A considerable proportion of German men who have sex with men (MSM) infected with HIV have a CD4 cell count below 350 cells/μl at time of diagnosis and are thus defined as "late...

  • HIV AND SEXUALLY TRANSMITTED INFECTIONS AMONG YOUTHS: A BRAZILIAN PERCEPTION. Schuelter-Trevisol, Fabiana; da Silva, Maricele Almeida; Claudino, Dikson; Gonçalves e. Silva, Helena Caetano; Mendes Marcon, Chaiana Esmeraldino; Plax, Kathryn // American Journal of Public Health;Nov2015, Vol. 105 Issue 11, pe5 

    A letter to the editor is presented in response to the article "HIV and Sexually Transmitted Infection Testing Among High-Risk Youths: Supporting Positive Opportunities With Teens" by K. Plax, J. Garbutt, and G.N. Kaushik which appears in a 2015 issue, and it mentions Brazilian national health.

  • FDA approves quicker test for chlamydia.  // Jet;7/12/93, Vol. 84 Issue 11, p28 

    Reports on the Food & Drug Administration's approval of a quicker, more accurate test for chlamydia. Chlamydia as a sexually transmitted disease afflicting millions of Americans; Disease leading to sterility and infertility; Detecting the disease through a male urine specimen; Men as primary...

  • Detecting sexually transmitted diseases.  // USA Today Magazine;Oct97, Vol. 126 Issue 2629, p10 

    Introduces the URIprobe, an amplified DNA probe technology used to detect sexually transmitted diseases in patients. The importance of early detection; The URIprobe's demonstration of a sensitivity that is greater than the standard tissue culture for chlamydia; Advantages of the URIprobe.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics